Fenofibrate, CAS number 49562-28-9, is known as the brand name Lipofen, which is marketed by Cipher-Kowa Pharmaceuticals. The patent for Lipofen is due to expire on January 10, 2015. Other recognizable brands of fenofibrate are Tricor, which has a patent expiration of January 9, 2018 and Antara, which has a patent expiration set for August[…]
Fenofibrate Safe for Patients with Type 2 Diabetes
Cardiovascular Agent, Drug Research & Development API, Patent Expiration 2015, Patent Expiration 2018, Patent Expiration 2020 Tags: HDLLDL Aug 15, 2012
Dalcetrapib a Potential Game Changer for Cholesterol Management
Drug Research & Development API Tags: HDL Apr 02, 2012
Dalcetrapib JTT-705 CAS# 211513-37-0, is in experimental stages and clinical development for prevention of cardiovascular events. Developed by Roche to increase good cholesterol, or HDL, in patients, dalcetrapib has proved efficacy in studies thus far. Positive results from clinical trials have also shown no increase in blood pressure in patients studied. Data released from a[…]
Uses of Niceritrol Being a hypolipidemic drug, Niceritrol is used to affect the levels of cholesterol profile. Niceritrol can be used to lower the levels of cholesterol along with LDL (low density lipoprotein) while it increases the levels of HDL (high density lipoprotein) and the levels of healthy cholesterol. The medicine is used to treat[…]
